NCT01599091

Brief Summary

Porphyromonas gingivalis is one of the major bacteria involved in the formation and progression of chronic periodontitis. Pathogens invading the gingiva face the host's innate immune system at first and later on the acquired immune system which includes secreted antibodies and specialized cells. Although both the arms of the immune system are coordinated to overcome the infection, there are several known mechanisms which help pathogens as Porphyromonas gingivalis evade immunity. As a result, inflammatory mediators secreted by immune cells cause tissue damage and lead the inflammation process towards chronicity instead of clearing the pathogen. Up till recently most of the studies focused on the role of macrophages, dendritic cells and lymphocytes at the response to periodontal pathogenic bacteria while the role of fibroblasts (the most abundant cell in the connective tissue) was less examined. Fibroblasts are spindle shaped cells which have the ability to produce extra cellular matrix and respond to growth factors and cytokines. They are able to affect cells in the infected tissue and contribute to immune response efficiency. As known in the case of lymphocytes, fibroblasts also vary in subtypes, each differs in phenotype, immune interactions, extra cellular matrix production and destruction, migration abilities and so on. Two main fibroblasts subtypes in the oral cavity originate in the gingival tissue and the periodontal ligament anchoring teeth to the surrounding alveolar bone. Amongst the differences between the two are collagen production ability and receptors profile over the cell surface. Considering all that, the investigators aim to obtain and use periodontal ligament and gingival tissues removed anyways during common dental procedures in order to extract the different fibroblasts subtypes residing there and compare their response to Porphyromonas gingivalis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2012

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 15, 2012

Completed
17 days until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

August 14, 2020

Status Verified

September 1, 2013

Enrollment Period

4 years

First QC Date

May 3, 2012

Last Update Submit

August 13, 2020

Conditions

Keywords

FibroblastsPeriodontal ligamentGingivaPorphyromonas gingivalisChronic periodontitis( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)

Outcome Measures

Primary Outcomes (1)

  • Cytokines, inflammatory mediators and extracellular matrix proteins production and secretion in vitro by fibroblasts

    healthy patients undergoing tooth extraction will be asked permission to use the anyway extracted tooth and gingiva for basic laboratory research. Periodontal ligament and gingival fibroblasts will be harvested from the collected specimens. Protein production and secretion following in vitro stimulation of the fibroblasts with Porphyromonas gingivalis will be examined to assess their function during periodontal disease.

    primary outcome will be assessed in vitro within 15 years from specimen collection (basic research)

Secondary Outcomes (7)

  • RNA production in vitro

    outcome will be assessed in vitro within 15 years from specimen collection (basic research)

  • cells motion in vitro

    outcome will be assessed in vitro within 15 years from specimen collection (basic research)

  • Cytokines, inflammatory mediators and extracellular matrix proteins production and secretion by leukocyte cell lines in vitro

    outcome will be assessed in vitro within 15 years from specimen collection (basic research)

  • RNA production in vitro by leukocyte cell lines

    outcome will be assessed in vitro within 15 years from specimen collection (basic research)

  • Bacterial survival

    outcome will be assessed in vitro within 15 years from specimen collection (basic research)

  • +2 more secondary outcomes

Study Arms (1)

Fibroblast's donors

Patients undergoing tooth extraction will be asked permission to use the anyway extracted teeth and gingiva in order to harvest fibroblasts for further basic research.

Other: Specimens collection

Interventions

Tooth extraction will be preformed in the regular way regardless of the study. Patients will be asked permission to obtain the extracted tooth and excess of gingival remnants for further in vitro investigation in the main investigator's laboratory.

Fibroblast's donors

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healty over 18 years of age eligible for signing patients that go through tooth extraction for reasons not related to the study.

You may qualify if:

  • Healthy men and women over 18 years of age, eligible for signing
  • Patient in need for a tooth extraction regardless of the study
  • Patient understanding and in consent to the character and the purpose of the study
  • Patient with healthy gingival and connective tissue surrounding the tooth to be extracted

You may not qualify if:

  • Pregnant or nursing women. children or non judgemental patients
  • Patient undergoing tooth extraction due to periodontitis or any reason related to a problem in the tooth connective tissue
  • patient with a Rontgenic bone loss around the tooth to be extracted.
  • Patient with any oral disease other than gingivitis.
  • Patients with need of pre-medication prior to invasive procedures.
  • Patients with background disease or regular use of medications
  • Patients treated with antibiotics in the 2 months preceding the tooth extraction.
  • Smoking patients.
  • Patients with alcohol abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

: Hadassah Medical Organization

Jerusalem, Israel

Location

Related Publications (1)

  • Somerman MJ, Archer SY, Imm GR, Foster RA. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res. 1988 Jan;67(1):66-70. doi: 10.1177/00220345880670011301.

    PMID: 11039048BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Anyway extracted teeth and gingiva. Patients undergoing tooth extraction will be asked permission to use the anyway extracted teeth and gingiva in order to harvest fibroblasts for further basic research.

MeSH Terms

Conditions

Periodontal DiseasesChronic Periodontitis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesPeriodontitisChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2012

First Posted

May 15, 2012

Study Start

June 1, 2012

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

August 14, 2020

Record last verified: 2013-09

Locations